Is platinum present in blood and urine from treatment givers during hyperthermic intraperitoneal chemotherapy?

Journal of Oncology

Volumn , Issue , 2010, Pages

  Mahteme, Haile ^a   Nslund Andréasson, Sara ^a   Anundi, Helena ^a   Thorén, Sig Britt ^a   Ehrsson, Hans ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; FLUOROURACIL; FOLINIC ACID; GLUCOSE; MITOMYCIN C; OXALIPLATIN; PLATINUM;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER CHEMOTHERAPY; CARCINOMATOUS PERITONITIS; CASE REPORT; CLINICAL ARTICLE; COLORECTAL CANCER; DRUG MEGADOSE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; ORGAN PERFUSION; PROTECTIVE CLOTHING; RISK ASSESSMENT; SURGEON; URINE LEVEL;

EID: 77955396214     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2010/649719     Document Type: Article

References (28)

1. Mahteme H., Phlman L., Glimelius B., Graf W., Prognosis after surgery in patients with incurable rectal cancer: a population-based study British Journal of Surgery 1996 83 8 1116 1120
2. Assersohn L., Norman A., Cunningham D., Benepal T., Ross P. J., Oates J., Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma British Journal of Cancer 1999 79 11-12 1800 1805
3. Sadeghi B., Arvieux C., Glehen O., Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study Cancer 2000 88 2 358 363
4. Verwaal V. J., van Ruth S., Witkamp A., Boot H., van Slooten G., Zoetmulder F. A. N., Long-term survival of peritoneal carcinomatosis of colorectal origin Annals of Surgical Oncology 2005 12 1 65 71
5. van Leeuwen B. L., Graf W., Phlman L., Mahteme H., Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis Annals of Surgical Oncology 2008 15 3 745 753
6. Elias D., Blot F., El Otmany A., Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy Cancer 2001 92 1 71 76
7. Giacchetti S., Perpoint B., Zidani R., Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer Journal of Clinical Oncology 2000 18 1 136 147
8. de Gramont A., Figer A., Seymour M., Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer Journal of Clinical Oncology 2000 18 16 2938 2947
9. Elias D., Bonnay M., Puizillou J. M., Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution Annals of Oncology 2002 13 2 267 272 (Pubitemid 34704979)
10. Elias D., Raynard B., Bonnay M., Pocard M., Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: pharmacologic studies European Journal of Surgical Oncology 2006 32 6 607 613
11. White S. K., Stephens A. D., Dowjat B., Sugarbaker P. H., Sugarbaker P. H., Safety considerations in the use of intraoperative intraperitoneal chemotherapy Peritoneal Carcinomatosis: Principles of Management 1996 Boston, Mass, USA Kluwer Academic Publishers 311 316
12. Yodaiken R. E., Bennett D., OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs American Journal of Hospital Pharmacy 1986 43 5 1193 1204
13. Guerbet M., Goull J. P., Lubrano J., Evaluation of the risk of contamination of surgical personnel by vaporization of oxaliplatin during the intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) European Journal of Surgical Oncology 2007 33 5 623 626
14. Gonzlez-Bayn L., Gonzlez-Moreno S., Ortega-Prez G., Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion European Journal of Surgical Oncology 2006 32 6 619 624
15. Sugarbaker P. H., Successful management of microscopic residual disease in large bowel cancer Cancer Chemotherapy and Pharmacology 1999 43 supplement S15 S25
16. Sugarbaker P. H., Management of peritoneal-surface malignancy: the surgeon's role Langenbeck's Archives of Surgery 1999 384 6 576 587
17. U.S. Environmental Protection Agency, Method 200.7: Determination of Metals and Trace Elements in Water and Wastes by Inductively Coupled Plasma-Atomic Emission Spectrometry. revision 4.4, 1994
18. U.S. Environmental Protection Agency, Method 200.8: Determination of Trace Elements in Water and Wastes by Inductively Coupled Plasma-Mass Spectrometry. revision 5.4, 1994
19. Jerremalm E., Wallin I., Ehrsson H., New insights into the biotransformation and pharmacokinetics of oxaliplatin Journal of Pharmaceutical Sciences 2009 98 11 3879 3885
20. Lvi F., Metzger G., Massari C., Milano G., Oxaliplatin: pharmacokinetics and chronopharmacological aspects Clinical Pharmacokinetics 2000 38 1 1 21
21. Mahteme H., Wallin I., Glimelius B., Phlman L., Ehrsson H., Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion European Journal of Clinical Pharmacology 2008 64 9 907 911
22. Stuart O. A., Stephens A. D., Welch L., Sugarbaker P. H., Safety monitoring of the coliseum technique for heated intraoperative intraperitoneal chemotherapy with mitomycin C Annals of Surgical Oncology 2002 9 2 186 191
23. Nygren O., Lundgren C., Determination of platinum in workroom air and in blood and urine from nursing staff attending patients receiving cisplatin chemotherapy International Archives of Occupational and Environmental Health 1997 70 3 209 214
24. Harmon B. V., Takano Y. S., Winterford C. M., Gob G. C., The role of apoptosis in the response of cells and tumours to mild hyperthermia International Journal of Radiation Biology 1991 59 2 489 501
25. Christophi C., Winkworth A., Muralihdaran V., Evans P., The treatment of malignancy by hyperthermia Surgical Oncology 1998 7 1-2 83 90
26. Rietbroek R. C., van de Vaart P. J. M., Haveman J., Hyperthermia enhances the cytotoxicity and platinum-DNA adduct formation of lobaplatin and oxaliplatin in cultured SW 1573 cells Journal of Cancer Research and Clinical Oncology 1997 123 1 6 12
27. NIOSH ALERT, Preventing Occupational Exposures to Antineoplastic Sand Other Hazardous Drugs in Health Care Settings NIOSH Publication 2004 2004-165 Department of Health and Human Services. Centers for Disease Control and Prevention. DHHS. http://www.cdc.gov/niosh/
28. White S. K., Stephens A. D., Sugarbaker P. H., Hyperthermic intraoperative intraperitoneal chemotherapy safety considerations AORN Journal 1996 63 4 716 724